Total Valuation
MYUNGMOON Pharm Co., Ltd. has a market cap or net worth of ₩40.85B. The enterprise value is ₩110.42K.
Market Cap₩40.85B
Enterprise Value₩110.42K
Share Statistics
MYUNGMOON Pharm Co., Ltd. has 33,953,453 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding33,953,453
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
MYUNGMOON Pharm Co., Ltd.’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is 1.58%.
Return on Equity (ROE)0.02
Return on Assets (ROA)<0.01
Return on Invested Capital (ROIC)1.58%
Return on Capital Employed (ROCE)0.04
Revenue Per Employee631.87M
Profits Per Employee6.13M
Employee Count309
Asset Turnover0.72
Inventory Turnover2.27
Valuation Ratios
The current PE Ratio of MYUNGMOON Pharm Co., Ltd. is ―. MYUNGMOON Pharm Co., Ltd.’s PEG ratio is -0.20.
PE Ratio―
PS Ratio0.32
PB Ratio0.64
Price to Fair Value0.64
Price to FCF-7.42
Price to Operating Cash Flow-11.71
PEG Ratio-0.20
Income Statement
In the last 12 months, MYUNGMOON Pharm Co., Ltd. had revenue of 195.25B and earned 1.90B in profits. Earnings per share was 56.70.
Revenue195.25B
Gross Profit107.19B
Operating Income6.83B
Pretax Income2.65B
Net Income1.90B
EBITDA10.13B
Earnings Per Share (EPS)56.70
Cash Flow
In the last 12 months, operating cash flow was -3.55B and capital expenditures -6.36B, giving a free cash flow of -9.91B billion.
Operating Cash Flow-3.55B
Free Cash Flow-9.91B
Free Cash Flow per Share-291.84
Dividends & Yields
MYUNGMOON Pharm Co., Ltd. pays an annual dividend of ₩95.424, resulting in a dividend yield of 1.67%
Dividend Per Share₩95.424
Dividend Yield1.67%
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.05
52-Week Price Change-25.95%
50-Day Moving Average1.22K
200-Day Moving Average1.57K
Relative Strength Index (RSI)48.26
Average Volume (3m)288.99K
Important Dates
MYUNGMOON Pharm Co., Ltd. upcoming earnings date is Nov 12, 2026, TBA (Confirmed).
Last Earnings DateAug 14, 2026
Next Earnings DateNov 12, 2026
Ex-Dividend Date―
Financial Position
MYUNGMOON Pharm Co., Ltd. as a current ratio of 0.96, with Debt / Equity ratio of 89.30%
Current Ratio0.96
Quick Ratio0.55
Debt to Market Cap1.56
Net Debt to EBITDA9.16
Interest Coverage Ratio1.34
Taxes
In the past 12 months, MYUNGMOON Pharm Co., Ltd. has paid 1.23B in taxes.
Income Tax1.23B
Effective Tax Rate0.46
Enterprise Valuation
MYUNGMOON Pharm Co., Ltd. EV to EBITDA ratio is 15.36, with an EV/FCF ratio of -18.39.
EV to Sales0.80
EV to EBITDA15.36
EV to Free Cash Flow-18.39
EV to Operating Cash Flow-91.32
Balance Sheet
MYUNGMOON Pharm Co., Ltd. has ₩24.31B in cash and marketable securities with ₩87.15B in debt, giving a net cash position of -₩62.84B billion.
Cash & Marketable Securities₩24.31B
Total Debt₩87.15B
Net Cash-₩62.84B
Net Cash Per Share-₩1.85K
Tangible Book Value Per Share₩3.06K
Margins
Gross margin is 57.27%, with operating margin of 3.50%, and net profit margin of 0.97%.
Gross Margin57.27%
Operating Margin3.50%
Pretax Margin1.36%
Net Profit Margin0.97%
EBITDA Margin5.19%
EBIT Margin3.50%
Analyst Forecast
The average price target for MYUNGMOON Pharm Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast4.75%
EPS Growth Forecast-237.25%